Search results
About Heather Bresch. In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year....
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
Jul 29, 2019 · Bresch is set to collect about $37.6 million with the change in leadership, per a Mylan proxy filing highlighted in a Monday note by Wells Fargo analyst David Maris. She's been among the...
Nov 19, 2020 · The estimated Net Worth of Heather M Bresch is at least $31.7 Million dollars as of 2 March 2020. Ms. Bresch owns over 143,709 units of Mylan NV stock worth over $4,802,534 and over the last 9 years she sold MYL stock worth over $8,385,000. In addition, she makes $18,509,300 as Chief Executive Officer and Executive Director at Mylan NV.
Mar 17, 2022 · With a final hearing set for July, the deal puts Heather Bresch, Manchin’s daughter and Mylan’s former CEO, on track to dodge legal repercussion from a yearslong saga involving allegations of ...
Jul 29, 2019 · The new company would have $24.5 billion in total debt. The deal has been approved by Mylan and Pfizer's boards but would have to be approved by Mylan shareholders.
Heather Bresch. Chief Executive Officer<br />Mylan. Heather Bresch is chief executive officer of Mylan, one of the largest generics and specialty pharmaceutical companies in the world. She also serves on the company’s board of directors.